08:58 AM EST, 03/08/2024 (MT Newswires) -- Health care stocks were steady pre-bell Friday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was down 0.1% recently.

Amylyx Pharmaceuticals ( AMLX ) was retreating by over 81% after saying its phase 3 clinical trial evaluating AMX0035 in patients with amyotrophic lateral sclerosis, or ALS, failed to meet the primary and secondary endpoints at week 48.